Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,928 | 37,437 | 32,298 | 44,812 | 60,213 |
| Marketable Securities | 128,846 | 148,412 | 156,566 | 159,299 | 133,162 |
| Receivables | 7,828 | 8,493 | 6,882 | 8,357 | 40,628 |
| TOTAL | $178,412 | $198,684 | $204,336 | $222,708 | $242,860 |
| Non-Current Assets | |||||
| PPE Net | 33,114 | 34,308 | 35,395 | 36,617 | 37,572 |
| Investments And Advances | 63,238 | 56,055 | 0 | 0 | 0 |
| Other Non-Current Assets | 39,940 | 40,456 | 41,001 | 41,704 | 42,561 |
| TOTAL | $136,292 | $130,819 | $76,396 | $78,321 | $80,133 |
| Total Assets | $314,704 | $329,503 | $280,732 | $301,029 | $322,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,363 | 1,885 | 1,948 | 3,547 | 4,756 |
| Accrued Expenses | 6,859 | 7,575 | 12,751 | 10,853 | 8,314 |
| Other current liabilities | 31,461 | 31,981 | 30,710 | 27,755 | 30,681 |
| TOTAL | $46,442 | $44,728 | $48,555 | $44,549 | $45,947 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 151,675 | 158,184 | 167,460 | 177,201 | 183,508 |
| TOTAL | $151,675 | $158,184 | $167,460 | $177,201 | $183,508 |
| Total Liabilities | $198,117 | $202,912 | $216,015 | $221,750 | $229,455 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,078 | 29,019 | 28,863 | 21,378 | 21,377 |
| Common Shares | 291 | 290 | 214 | 214 | 214 |
| Retained earnings | -429,958 | -416,867 | -404,929 | -386,229 | -367,974 |
| Other shareholders' equity | -734 | -329 | -339 | -402 | -224 |
| TOTAL | $116,587 | $126,591 | $64,717 | $79,279 | $93,538 |
| Total Liabilities And Equity | $314,704 | $329,503 | $280,732 | $301,029 | $322,993 |